Skip to content

To Study the Effect of Xi's Tangzu Recipe on Microinflammation of Diabetic Foot Gangrene Syndrome

To Study the Effect of Xi's Tangzu Recipe on Microinflammation of Diabetic Foot Gangrene Syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026861
Enrollment
Unknown
Registered
2019-10-24
Start date
2020-01-01
Completion date
Unknown
Last updated
2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot

Interventions

treatment group:Tangfoot recipe granule.
control group:placebo

Sponsors

Shanghai Yueyang Integrated Traditional Chinese Medicine and Western Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) According to the diagnostic criteria of WHO diabetic foot, the stage of diabetic foot was grade 0. (2) It meets the diagnostic criteria of DFTG latent syndrome. (3) Aged 30 to 85 years. (4) Informed consent has been signed. All those who meet the above conditions may be included.

Exclusion criteria

Exclusion criteria: (1) Diabetes mellitus caused by special causes, pregnancy DM. (2) pregnant or lactating women. (3) patients with serious heart, liver, kidney and other complications, or complicated with other serious primary diseases, mental illness. (4) ketoacidosis, hyperosmotic diabetes mellitus and severe infection occurred in recent 1 month. (5) neuropathy caused by other causes. (6) allergic to the relevant drugs in the treatment plan, which is not suitable for the patients with this treatment plan. (7) according to the judgment of the researchers, there are other cases in which the possibility of joining the group is reduced or complicated. (8) patients who are participating in clinical trials of other drugs or are taking other drugs for the treatment of diabetic foot. Compliance with any of the above clauses shall be excluded.

Design outcomes

Primary

MeasureTime frame
blood-glucose;Inflammatory Factor;Safety Index;Evaluation index of curative effect;

Secondary

MeasureTime frame
Biological index;

Countries

China

Contacts

Public ContactZhang Lei

Shanghai Yueyang Integrated Traditional Chinese Medicine and Western Medicine Hospital

see-eye@163.com+86 18601714757

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026